{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:15:56Z","timestamp":1772928956075,"version":"3.50.1"},"reference-count":12,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2131\/jts.51.173","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T22:10:14Z","timestamp":1772316614000},"page":"173-181","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the stability and cross-reactivity of zopiclone and eszopiclone using immunoassay kits"],"prefix":"10.2131","volume":"51","author":[{"given":"Takeshi","family":"Saito","sequence":"first","affiliation":[{"name":"Tokai University School of Medicine, Department of Emergency and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Namera","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Tokai University School of Medicine, Department of Emergency and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Morita","sequence":"additional","affiliation":[{"name":"Tokai University School of Medicine, Department of Emergency and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Tokai University School of Medicine, Department of Emergency and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Becquemont, L., Mouajjah, S., Escaffre, O., Beaune, P., Funck-Brentano, C. and Jaillon, P. (1999): Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism. Drug Metab. Dispos., <b>27<\/b>, 1068-1073.","DOI":"10.1016\/S0090-9556(24)15027-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Brielmaier, B.D. (2006): Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent. Proc. Bayl. Univ. Med. Cent., <b>19<\/b>, 54-59.","DOI":"10.1080\/08998280.2006.11928127"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Galloway, J.H., Marsh, I.D., Newton, C.M. and Forrest, A.R. (1999): A method for the rapid detection of the zopiclone degradation product 2-amino-5-chloropyridine. Sci. Justice, <b>39<\/b>, 253-256.","DOI":"10.1016\/S1355-0306(99)72056-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Kratzsch, C., Tenberken, O., Peters, F.T., Weber, A.A., Kraemer, T. and Maurer, H.H. (2004): Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography\/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom., <b>39<\/b>, 856-872.","DOI":"10.1002\/jms.599"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Liu, R., Liu, D., Zhang, J., Zang, H. and Gao, Y. (2020): Development of a novel tandem mass spectrometry method for the quantification of eszopiclone without interference from 2-amino-5-chloropyridine and application in a pharmacokinetic study of rat. J. Pharm. Biomed. Anal., <b>188<\/b>, 113363.","DOI":"10.1016\/j.jpba.2020.113363"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Mannaert, E., Tytgat, J. and Daenens, P. (1997): Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection. J. Anal. Toxicol., <b>21<\/b>, 208-212.","DOI":"10.1093\/jat\/21.3.208"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Najib, J. (2006): Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin. Ther., <b>28<\/b>, 491-516.","DOI":"10.1016\/j.clinthera.2006.04.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Nilsson, G.H., Kugelberg, F.C., Ahlner, J. and Kronstrand, R. (2014): Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-amino-5-chloropyridine in urine using LC-MS-MS. J. Anal. Toxicol., <b>38<\/b>, 327-334.","DOI":"10.1093\/jat\/bku042"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Nilsson, G.H., Kugelberg, F.C., Ahlner, J. and Kronstrand, R. (2015): Validation of an LC-MS\/MS method for the determination of zopiclone, N-desmethylzopiclone and 2-amino-5-chloropyridine in whole blood and its application to estimate the original zopiclone concentration in stored specimens. Int. J. Legal Med., <b>129<\/b>, 269-277.","DOI":"10.1007\/s00414-014-1049-2"},{"key":"10","doi-asserted-by":"publisher","unstructured":"R\u00f6sner, S. <i>et al<\/i>., (2018): Eszopiclone for insomnia. Cochrane Database Syst Rev. 10, No.: CD010703. DOI: 10.1002\/14651858.CD010703.pub2","DOI":"10.1002\/14651858.CD010703.pub2"},{"key":"11","unstructured":"Saito, T., et al. Screening and identification of azacyclonol and fexofenadine in human urine using LC\u2013MS\/MS. Chromatographia. Doi.org\/10.21203\/rs.3.rs-1987861\/v1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Segawa, H., Iwata, Y.T., Okada, Y., Yamamuro, T., Kuwayama, K., Tsujikawa, K. and Kanamori, T. (2023): Rapid enantiomeric analysis of zopiclone in serum by supercritical fluid chromatography-tandem mass spectrometry. J. Forensic Sci., <b>68<\/b>, 1352-1358.","DOI":"10.1111\/1556-4029.15279"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/3\/51_173\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:48:15Z","timestamp":1772858895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/3\/51_173\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.51.173","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}